Related Articles
Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B
Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
Brca1 is involved in tolerance to adefovir dipivoxil‑induced DNA damage
A novel method for the analysis of drug-resistant phenotypes of hepatitis B virus